- Filed
- Mar 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 11, 2025 | 51.51M sh |
| Current Liabilities | Q2 2025 · Jan 31, 2025 | $346.65K |
| Current Liabilities | Q2 2025 · Jul 31, 2024 | $219.01K |
| Total Liabilities | Q2 2025 · Jan 31, 2025 | $393.39K |
| Total Liabilities | Q2 2025 · Jul 31, 2024 | $288.11K |
| Current Assets | Q2 2025 · Jan 31, 2025 | $2.83K |
| Current Assets | Q2 2025 · Jul 31, 2024 | $1.84K |
| Total Assets | Q2 2025 · Jan 31, 2025 | $87.44K |
| Total Assets | Q2 2025 · Jul 31, 2024 | $105.99K |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 35.41M sh |
| Shares Diluted | Q2 2025 · Jan 31, 2024 | 35.41M sh |
| Operating Cash Flow | Q2 2025 · Jan 31, 2024 | −$86.33K |
| Stockholders Equity | Q2 2025 · Jan 31, 2024 | −$51.58K |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | −$12.36K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $49.72K |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Eps Diluted | Q2 2025 · Jan 31, 2024 | $0.00 |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $18.5K |
| Sga Expense | Q2 2025 · Jan 31, 2024 | $60.51K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$41.65K |
| Net Income | Q2 2025 · Jan 31, 2024 | −$104.64K |
| Net Income | Q2 2025 · Oct 31, 2023 | −$62.99K |
| Operating Income restated | Q2 2025 · Jan 31, 2024 | −$42.09K |
| Operating Income restated | Q2 2025 · Jan 31, 2024 | −$107K |
| Cost Of Revenue | Q2 2025 · Jan 31, 2024 | $0 |
| Cost Of Revenue restated | Q2 2025 · Jan 31, 2024 | $0 |
| Revenue | Q2 2025 · Jan 31, 2024 | $0 |
| Revenue restated | Q2 2025 · Jan 31, 2024 | $0 |